BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38043142)

  • 1. NK cells and the profile of inflammatory cytokines in the peripheral blood of patients with advanced carcinomas.
    Saito LM; Ortiz RC; Amôr NG; Lopes NM; Buzo RF; Garlet GP; Rodini CO
    Cytokine; 2024 Feb; 174():156455. PubMed ID: 38043142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immature and activated phenotype of blood NK cells is associated with acute rejection in adult liver transplant.
    Song S; Zhi Y; Tian G; Sun X; Chen Y; Qiu W; Jiao W; Huang H; Yu Y; Li M; Lv G
    Liver Transpl; 2023 Aug; 29(8):836-848. PubMed ID: 37002601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Hope for CD56
    Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
    Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-frequency, exhausted immune status of CD56
    Pan Z; Zhao R; Shen Y; Liu K; Xue W; Liang C; Peng M; Hu P; Chen M; Xu H
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108369. PubMed ID: 34844872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chemokines in the biology of natural killer cells.
    Maghazachi AA
    Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
    Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
    Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
    Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
    Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.
    Harlin H; Hanson M; Johansson CC; Sakurai D; Poschke I; Norell H; Malmberg KJ; Kiessling R
    J Immunol; 2007 Oct; 179(7):4513-9. PubMed ID: 17878347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
    Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
    Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
    Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
    BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
    PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure.
    Liu F; Duan X; Wan Z; Zang H; You S; Yang R; Liu H; Li D; Li J; Zhang Y; Xin S
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):605-613. PubMed ID: 27053076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation status of CD56
    Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.